These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29171039)

  • 1. One-year follow-up of a TRASER clinical trial for the treatment of nasal telangiectasias.
    Geddes-Bruce E; Hamill SS; Zachary CB; Friedman PM
    Lasers Surg Med; 2018 Jan; 50(1):61-63. PubMed ID: 29171039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRASER: An innovative device for the treatment of nasal telangiectasias.
    Friedman PM; Tolkachjov SN; Geddes ER; Tillman KA; Zachary CB
    Lasers Surg Med; 2017 Aug; 49(6):625-631. PubMed ID: 28382712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study.
    Suggs AK; Macri A; Richmond H; Munavalli G; Friedman PM
    Lasers Surg Med; 2020 Jan; 52(1):38-43. PubMed ID: 31709571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser.
    Tierney E; Hanke CW
    Lasers Surg Med; 2009 Oct; 41(8):555-62. PubMed ID: 19746429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of poikiloderma of Civatte using a redesigned pulsed dye laser with a 15 mm diameter treatment spot.
    Bernstein EF; Schomacker K; Paranjape A; Jones CJ
    Lasers Surg Med; 2019 Jan; 51(1):54-58. PubMed ID: 30480322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of laser therapy on quality of life in patients with radiation-induced breast telangiectasias.
    Rossi AM; Blank NR; Nehal K; Dusza S; Lee EH
    Lasers Surg Med; 2018 Apr; 50(4):284-290. PubMed ID: 29266570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of leg veins with combined pulsed dye and Nd:YAG lasers: 60 patients assessed at 6 months.
    Trelles MA; Weiss R; Moreno-Moragas J; Romero C; Vélez M; Alvarez X
    Lasers Surg Med; 2010 Nov; 42(9):609-14. PubMed ID: 20976800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telangiectasia of the face: risk factors for reappearance in patients treated with dye laser.
    Guida S; Galimberti MG; Bencini M; Pellacani G; Bencini PL
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1355-1359. PubMed ID: 27987316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of telangiectasias with a 595-nm pulsed dye laser following hemangioma involution: a retrospective analysis.
    Wu JP; Zhang L; Ge HS
    Lasers Med Sci; 2024 Jun; 39(1):164. PubMed ID: 38935161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment of Lower Extremity Telangiectasias Using 585-nm Pulsed-Dye Laser at Low Fluence Combined With Optical Coherence Tomography: A Case Report.
    Rajabi-Estarabadi A; Zheng C; Williams N; Smith SC; Nouri K; Kirsner RS
    J Drugs Dermatol; 2019 Nov; 18(11):1180-1182. PubMed ID: 31741363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive disseminated essential telangiectasia and erythrosis interfollicularis colli as examples for successful treatment with a high-intensity flashlamp.
    Wenzel SM; Hohenleutner U; Landthaler M
    Dermatology; 2008; 217(3):286-90. PubMed ID: 18698141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized settings for Nd:YAG laser treatments of leg telangiectasias.
    Christiansen K; Drosner M; Bjerring P
    J Cosmet Laser Ther; 2015 Apr; 17(2):69-76. PubMed ID: 25415373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple technique for treatment of nasal telangiectasia using trichloroacetic acid and CO2 laser.
    Kim YJ; Shin BS; Chung BS; Cho SH
    Dermatol Surg; 2002 Aug; 28(8):729-31. PubMed ID: 12174066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular-specific laser wavelength for the treatment of facial telangiectasias.
    Dudelzak J; Hussain M; Goldberg DJ
    J Drugs Dermatol; 2009 Mar; 8(3):227-9. PubMed ID: 19271368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias.
    Piccolo D; Crisman G; Kostaki D; Cannarozzo G; Sannino M; Chimenti S
    J Cosmet Laser Ther; 2016; 18(2):80-5. PubMed ID: 26736070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser.
    Parlette EC; Groff WF; Kinshella MJ; Domankevitz Y; O'Neill J; Ross EV
    Lasers Surg Med; 2006 Feb; 38(2):98-105. PubMed ID: 16240418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new technique for the treatment of nasal telangiectasia using atmospheric plasma (voltaic arc dermabrasion): Postoperative pain assessment by thermal infrared imaging.
    Scarano A; Petrini M; Inchingolo F; Lorusso F; Amuso D
    J Cosmet Dermatol; 2020 Nov; 19(11):2912-2918. PubMed ID: 32367634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized side-by-side study comparing alexandrite laser at different pulse durations for port wine stains.
    Carlsen BC; Wenande E; Erlendsson AM; Faurschou A; Dierickx C; Haedersdal M
    Lasers Surg Med; 2017 Jan; 49(1):97-103. PubMed ID: 27121176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the red nose with the argon laser.
    Dicken CH
    Mayo Clin Proc; 1986 Nov; 61(11):893-5. PubMed ID: 2945060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.